Interleukin Genetics, Inc. announced that Chief Executive Officer Lewis H. Bender will speak at the Washington G-2 Reports' Business & Financial Strategies for Molecular Diagnostics conference, taking place February 2-4, 2009 in Fort Lauderdale, FL. As part of his discussion, Mr. Bender will address the opportunities and challenges that exist within the genetic personalized health industry. The presentation will center on navigating genetic tests through consumer and physician channels from a regulatory, scientific and marketing standpoint, while providing a case study example to demonstrate their medical utility. "The benefits of genetic testing across channels are significant," said Bender. "Not only can drug developers improve their probability of success in clinical trials by using genetic biomarkers to screen out non-responders, but consumers can use genetic tests to improve wellness by personalizing their diet, environment and lifestyle choices best suited for their genetic makeup." Washington G-2 Reports' Molecular Diagnostics conference will provide expert insight and advice on how laboratories can and are successfully integrating molecular diagnostics into their business strategies, given the current regulatory business environment.
Interleukin Genetics to Present at G-2 Reports' Molecular Diagnostic Conference
News Feb 03, 2009